Showing results (41-50 of 48) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Liver International : Official Journal of the International Association for the Study of the Liver|May 17, 2021
Early virological response in six patients with hepatitis D virus infection and compensated cirrhosis treated with Bulevirtide in real-lifeTarik Asselah, Dimitri Loureiro, Fréderic Le Gal, et al.Antimicrobial Agents and Chemotherapy|July 2, 2014
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patientsCédric Laouénan, Patrick Marcellin, Martine Lapalus, et al.Cytokine|March 12, 2002
Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapyManuela G Neuman, Jean-Pierre Benhamou, Marc Bourliere, et al.Hepatology (Baltimore, Md.)|August 16, 2022
Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitisDimitri Loureiro, Issam Tout, Stéphanie Narguet, et al.Journal of Hepatology|September 29, 2011
IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis CTarik Asselah, Simon De Muynck, Philippe Broët, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 9, 2017
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programmeChristophe Hézode, Pascal Lebray, Victor De Ledinghen, et al.JAMA|May 6, 2015
Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infectionFred Poordad, William Sievert, Lindsay Mollison, et al.World Journal of Hepatology|January 14, 2021
Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virusAnaïs Brayette, Marie Essig, Paul Carrier, et al.Pageof 5